3/5
08:34 am
brtx
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 [Yahoo! Finance]
Low
Report
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 [Yahoo! Finance]
3/5
08:00 am
brtx
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
Medium
Report
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
3/4
08:12 am
brtx
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy [Yahoo! Finance]
Medium
Report
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy [Yahoo! Finance]
3/4
08:00 am
brtx
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
Medium
Report
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
2/24
08:30 am
brtx
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
High
Report
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
2/13
08:30 pm
brtx
BioRestorative Announces Closing of $5.0 Million Public Offering
Low
Report
BioRestorative Announces Closing of $5.0 Million Public Offering
2/12
01:03 am
brtx
BioRestorative prices $5M stock offering [Seeking Alpha]
High
Report
BioRestorative prices $5M stock offering [Seeking Alpha]
2/11
10:30 pm
brtx
BioRestorative Announces Pricing of $5.0 Million Public Offering
High
Report
BioRestorative Announces Pricing of $5.0 Million Public Offering
2/11
07:30 am
brtx
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
High
Report
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
2/10
08:00 am
brtx
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
High
Report
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
2/1
09:11 pm
brtx
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]
Low
Report
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]